Strategic Pathways to SpaceX Exposure Ahead of Planned IPO

SpaceX has officially filed plans to transition to a public company, sparking significant interest among retail and institutional investors. While a direct initial public offering (IPO) is the most anticipated route, several existing financial instruments currently provide exposure to the private aerospace giant. For those unwilling to wait for the IPO, indirect investment via specialized ETFs, private equity funds, and corporate stakeholders offers a viable alternative. These options vary in accessibility, ranging from open-market ETFs to funds restricted to accredited investors. The Ark Venture Fund (ARKVX) currently holds SpaceX as its largest position, representing 17% of the fund's total assets. Similarly, the ER Shares Private-Public Crossover ETF (XOVR) maintains a heavy concentration, with SpaceX accounting for 27% of its portfolio. For those trading on the NYSE, Destiny Tech 100 (DXYZ) allocates 16.2% of its holdings to the company. Beyond funds, corporate holdings provide another entry point. Alphabet holds a stake exceeding 6% in SpaceX, while EchoStar is pursuing a deal to acquire shares, pending regulatory approval. Additionally, SoFi Technologies provides access to the Cosmos Fund, though this vehicle is limited to accredited investors. The anticipation of a SpaceX IPO typically drives volatility in these proxy vehicles. As the company moves closer to its public debut, the valuation of these funds may fluctuate based on perceived SpaceX valuations and the eventual pricing of the IPO.